Studies related to Reaction Time and Ginkgo biloba

A double-blind placebo-controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly
Effect Increase
Trial Design doubleblind
Trial Length 16months
Number of Subjects 54
Sex mixed
Notes for this study:
Supplementation of EGb-761 daily over the course of 3 months in elderly persons experiencing cognitive decline but not diagnosed with dementia or other neurodegenerative diseases noted improvements in cognition and reaction time relative to placebo.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.